Treatment of Fungal Urinary Tract Infections
For symptomatic fungal urinary tract infections, oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks is the first-line treatment for fluconazole-susceptible organisms. 1, 2
Diagnostic Considerations
- Differentiate between contamination, colonization, and true infection
- True infection typically presents with symptoms of UTI (dysuria, frequency, urgency)
- Asymptomatic candiduria generally does not require treatment except in:
- Neutropenic patients
- Patients undergoing urological procedures
- Low birth weight infants
Treatment Algorithm Based on Candida Species
Fluconazole-Susceptible Candida (including C. albicans)
- First-line: Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks 1, 2
- For pyelonephritis: Increase dose to 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
- Treatment should continue until symptoms resolve and urine cultures become negative 2
Fluconazole-Resistant C. glabrata
- First-line: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
- Alternative options:
C. krusei Infections
- First-line: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
Critical Adjunctive Measures
- Remove indwelling bladder catheters if feasible (strong recommendation) 1, 2
- Eliminate urinary tract obstruction if present 1
- Consider removal or replacement of nephrostomy tubes or stents 1
- Discontinue unnecessary antibiotics 2
Special Considerations
Fungus Balls
- Require aggressive surgical debridement in addition to antifungal therapy 1
- Consider local irrigation with amphotericin B (50 mg/L sterile water) if direct access to collecting system is available 1
- Other methods include intermittent saline irrigation, debulking through percutaneous device, and irrigation with streptokinase 1
Prostatitis and Epididymo-orchitis
- Fluconazole is the agent of choice 1
- May require surgical drainage of abscesses or other surgical debridement 1
Important Pharmacological Considerations
- Fluconazole achieves high concentrations in urine, making it ideal for UTIs 1, 2
- Echinocandins and newer azoles (voriconazole, posaconazole) should NOT be used for uncomplicated fungal UTIs due to poor urinary concentrations 2
- Liposomal amphotericin B should NOT be used for lower UTIs due to inadequate urine concentrations 2
- Flucytosine should not be used as monotherapy due to risk of resistance development 2
Common Pitfalls to Avoid
- Treating asymptomatic candiduria unnecessarily 2
- Failing to remove indwelling catheters or address underlying conditions 2
- Using antifungals with poor urinary concentrations 2
- Not distinguishing between colonization and true infection 2
- Inadequate duration of therapy for symptomatic infections 2
Follow-up
- Obtain follow-up urine cultures to assess treatment effectiveness 2
- Monitor for symptom resolution 2
- Screen for potential complications or dissemination 2
By following this treatment algorithm and addressing underlying risk factors, most fungal UTIs can be effectively managed with appropriate antifungal therapy.